Jae Seung Bang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jae Seung Bang has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
O-Ki Kwon
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea
15 shared publicationsChang Wan Oh
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea
14 shared publications- Chang Wan Oh
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
13 shared publications - Si Un Lee
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Republic of Korea
13 shared publications - Tackeun Kim
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
12 shared publications Seung Pil Ban
Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-si, Korea
9 shared publications
Latest Publications
- Open Access
- 8 May 2026
- Published by Korean Society of Cerebrovascular Surgeons/Korean Society of Endovascular Surgery in Journal of Cerebrovascular and Endovascular Neurosurgery
- Vol. 28 (3) , 312-315
Incidental meningiomas discovered during intracranial aneurysm clipping: The importance of intraoperative dural biopsy
The coexistence of an intracranial aneurysm (IA) and meningioma (MNG) is a rare clinical entity (0.13-1.17%). However, the prevalence of clinically occult MNGs may be underestimated, as routine vascular imaging often misses small lesions.We present two female patients with a history of multiple or recurrent IAs and prior endovascular treatment. During surgical clipping via a pterional approach, suspicious dural lesions—hypervascularization and thickening around the anterior clinoid process—were incidentally identified, despite being invisible on preoperative imaging. Intraoperative biopsies confirmed these lesions as MNGs.While the exact pathogenesis or underlying association remains speculative, these cases highlight the critical importance of unexpected intraoperative findings. Neurosurgeons must maintain high vigilance and strongly consider active biopsy of abnormal dura mater encountered during IA clipping, particularly in patients with multiple IAs or previous endovascular treatments.
- 8 May 2026
- Published by Korean Society of Cerebrovascular Surgeons/Korean Society of Endovascular Surgery in Journal of Cerebrovascular and Endovascular Neurosurgery
- Vol. 28 (3) , 312-315
Open AccessIncidental meningiomas discovered during intracranial aneurysm clipping: The importance of intraoperative dural biopsy
The coexistence of an intracranial aneurysm (IA) and meningioma (MNG) is a rare clinical entity (0.13-1.17%). However, the prevalence of clinically occult MNGs may be underestimated, as routine vascular imaging often misses small lesions.We present two female patients with a history of multiple or recurrent IAs and prior endovascular treatment. During surgical clipping via a pterional approach, suspicious dural lesions—hypervascularization and thickening around the anterior clinoid process—were incidentally identified, despite being invisible on preoperative imaging. Intraoperative biopsies confirmed these lesions as MNGs.While the exact pathogenesis or underlying association remains speculative, these cases highlight the critical importance of unexpected intraoperative findings. Neurosurgeons must maintain high vigilance and strongly consider active biopsy of abnormal dura mater encountered during IA clipping, particularly in patients with multiple IAs or previous endovascular treatments.
- 26 November 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (8) , 1159-1169
Risk of peripartum cerebrovascular events in women with moyamoya disease: A multicenter cohort study
Background: Pregnancy and delivery are known to increase the risk of cerebrovascular events (CVEs) in patients with moyamoya disease (MMD). This study determined the frequency, risk factors, and outcome of CVEs during pregnancy in MMD. Methods: We conducted a multicenter study involving 171 MMD patients with 196 deliveries across four Korean tertiary institutions between 1990 and 2023. Data on MMD-related clinical, imaging, and operative findings were collected. We analyzed CVEs and pregnancy outcomes, including delivery mode and anesthesia. Univariate and multivariate analyses were performed to identify risk factors for peripartum CVEs. Results: Peripartum CVEs occurred in 5.6% of pregnancies, with intracerebral hemorrhage being the most common, followed by cerebral infarction. CVEs were more common in women diagnosed with MMD during pregnancy (85.7% vs. 2.6% in women diagnosed before pregnancy) and in women who had not completed revascularization before pregnancy or were hemodynamically unstable: 55.6% versus 1.1%. Delivery mode and anesthesia showed no significant association with the occurrence of CVEs. Multivariate analysis revealed that the “non-revascularized or hemodynamically unstable” group remained a significant risk factor for peripartum CVEs (adjusted odds ratio (OR) = 353.23, P < 0.001). CVEs resulted in maternal functional impairment in 4 of 11 affected cases (36.4%) and fetal loss in 2 of 11 cases (18.2%). Conclusion: This study highlights the protective effect of revascularization on peripartum CVEs and proposes a structured clinical protocol, recommending prepregnancy hemodynamic assessment and neurosurgical consultation. Women diagnosed with MMD during pregnancy and those in the “non-revascularized or hemodynamically unstable” group should be considered a high-risk group for peripartum CVEs.
- 26 November 2025
- Published by SAGE Publications in International Journal of Stroke
- Vol. 21 (8) , 1159-1169
Risk of peripartum cerebrovascular events in women with moyamoya disease: A multicenter cohort study
Background: Pregnancy and delivery are known to increase the risk of cerebrovascular events (CVEs) in patients with moyamoya disease (MMD). This study determined the frequency, risk factors, and outcome of CVEs during pregnancy in MMD. Methods: We conducted a multicenter study involving 171 MMD patients with 196 deliveries across four Korean tertiary institutions between 1990 and 2023. Data on MMD-related clinical, imaging, and operative findings were collected. We analyzed CVEs and pregnancy outcomes, including delivery mode and anesthesia. Univariate and multivariate analyses were performed to identify risk factors for peripartum CVEs. Results: Peripartum CVEs occurred in 5.6% of pregnancies, with intracerebral hemorrhage being the most common, followed by cerebral infarction. CVEs were more common in women diagnosed with MMD during pregnancy (85.7% vs. 2.6% in women diagnosed before pregnancy) and in women who had not completed revascularization before pregnancy or were hemodynamically unstable: 55.6% versus 1.1%. Delivery mode and anesthesia showed no significant association with the occurrence of CVEs. Multivariate analysis revealed that the “non-revascularized or hemodynamically unstable” group remained a significant risk factor for peripartum CVEs (adjusted odds ratio (OR) = 353.23, P < 0.001). CVEs resulted in maternal functional impairment in 4 of 11 affected cases (36.4%) and fetal loss in 2 of 11 cases (18.2%). Conclusion: This study highlights the protective effect of revascularization on peripartum CVEs and proposes a structured clinical protocol, recommending prepregnancy hemodynamic assessment and neurosurgical consultation. Women diagnosed with MMD during pregnancy and those in the “non-revascularized or hemodynamically unstable” group should be considered a high-risk group for peripartum CVEs.
- Open Access
- 25 October 2025
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 45 (2) , 101646
Effect of Preoperative Intravenous Ferric Carboxymaltose on Postoperative Transfusion Reduction in Iron Deficiency Anemia Patients Scheduled for Clipping Surgery for Unruptured Intracranial Aneurysms: The PICASA Trial — A Single Center, Single-Blind Randomized Clinical Trial
- 25 October 2025
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 45 (2) , 101646
Open AccessEffect of Preoperative Intravenous Ferric Carboxymaltose on Postoperative Transfusion Reduction in Iron Deficiency Anemia Patients Scheduled for Clipping Surgery for Unruptured Intracranial Aneurysms: The PICASA Trial — A Single Center, Single-Blind Randomized Clinical Trial
- 10 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (1) , 113-121
Comparison of Triple Antiplatelet (Aspirin, Clopidogrel, and Cilostazol) and Modified Dual Antiplatelet (Aspirin and Low-Dose Prasugrel) Therapy in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for an Unruptured Intracranial Aneurysm: A Prospective Randomized Clinical Trial
BACKGROUND AND OBJECTIVES: Modified antiplatelet therapies in patients with high on-treatment platelet reactivity (HTPR) remains unknown in neurointerventional treatment. We aimed to compare the safety and effectiveness of two different modified antiplatelet therapies in patients with HTPR undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm. METHODS: We conducted a prospective, randomized clinical trial. Participants with HTPR were randomly assigned (1:1) to the triple antiplatelet therapy (TAT, addition of cilostazol) or modified dual antiplatelet therapy (MDAT, switched from clopidogrel to low-dose prasugrel) group. The primary outcome was all-bleeding-events during the 90-day follow-up period. The secondary outcomes were thromboembolic events and changes in the P2Y12 reaction unit (PRU) value throughout the follow-up period. Intention-to-treat (ITT) and per-protocol (PP) analyses were performed. RESULTS: In total, 172 of the 198 participants maintained initial antiplatelet therapy for 90 days. There was no significant difference in the all-bleeding-event rate between the two groups, both in the ITT population (hazard ratio [HR], 0.77 [95% CI, 0.49-1.20]; P = .26) and the PP population (HR, 0.79 [95% CI, 0.50-1.30]; P = .34). The thromboembolic event rate did not differ between the 2 groups in either the ITT population (HR, 0.33 [95% CI, 0.03-3.20]; P = .34) or the PP population (HR, 0.42 [95% CI, 0.04-4.70]; P = .48). Compared with those in the TAT group, the PRU values in the MDAT group greatly decreased over time, particularly for PRU after loading. CONCLUSION: Among patients with HTPR who underwent stent-assisted coil embolization for an unruptured intracranial aneurysm, there was no significant difference between the TAT and MDAT groups regarding the risk of all bleeding events and thromboembolic events during the 90 days of follow-up.
- 10 October 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 99 (1) , 113-121
Comparison of Triple Antiplatelet (Aspirin, Clopidogrel, and Cilostazol) and Modified Dual Antiplatelet (Aspirin and Low-Dose Prasugrel) Therapy in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for an Unruptured Intracranial Aneurysm: A Prospective Randomized Clinical Trial
BACKGROUND AND OBJECTIVES: Modified antiplatelet therapies in patients with high on-treatment platelet reactivity (HTPR) remains unknown in neurointerventional treatment. We aimed to compare the safety and effectiveness of two different modified antiplatelet therapies in patients with HTPR undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm. METHODS: We conducted a prospective, randomized clinical trial. Participants with HTPR were randomly assigned (1:1) to the triple antiplatelet therapy (TAT, addition of cilostazol) or modified dual antiplatelet therapy (MDAT, switched from clopidogrel to low-dose prasugrel) group. The primary outcome was all-bleeding-events during the 90-day follow-up period. The secondary outcomes were thromboembolic events and changes in the P2Y12 reaction unit (PRU) value throughout the follow-up period. Intention-to-treat (ITT) and per-protocol (PP) analyses were performed. RESULTS: In total, 172 of the 198 participants maintained initial antiplatelet therapy for 90 days. There was no significant difference in the all-bleeding-event rate between the two groups, both in the ITT population (hazard ratio [HR], 0.77 [95% CI, 0.49-1.20]; P = .26) and the PP population (HR, 0.79 [95% CI, 0.50-1.30]; P = .34). The thromboembolic event rate did not differ between the 2 groups in either the ITT population (HR, 0.33 [95% CI, 0.03-3.20]; P = .34) or the PP population (HR, 0.42 [95% CI, 0.04-4.70]; P = .48). Compared with those in the TAT group, the PRU values in the MDAT group greatly decreased over time, particularly for PRU after loading. CONCLUSION: Among patients with HTPR who underwent stent-assisted coil embolization for an unruptured intracranial aneurysm, there was no significant difference between the TAT and MDAT groups regarding the risk of all bleeding events and thromboembolic events during the 90 days of follow-up.
- 26 April 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-11
Comparative study of the refined mini-pterional approach with reduced skin incision versus the conventional mini-pterional approach for clipping unruptured middle cerebral artery aneurysms: a propensity score-matched analysis
This study aimed to compare the safety and efficacy of the refined mini-pterional approach (rMP), utilizing a smaller skin incision, with the conventional mini-pterional approach (cMP) for microsurgical clipping of unruptured intracranial aneurysms (UIAs) in the middle cerebral artery (MCA). A retrospective cohort analysis was conducted, including 186 patients: 92 patients who underwent rMP between 2021 and 2022, and 94 patients treated with cMP between 2019 and 2020. Clinical outcomes included length of stay (LOS, days), operative time (minutes), intraoperative blood loss (ml), aneurysm obliteration rate, postoperative complication rates, and the severity of temporalis muscle atrophy (TMA). Propensity score matching (PSM) was employed to minimize selection bias and ensure comparability of baseline characteristics between the two cohorts. Following PSM, the rMP group demonstrated significantly reduced LOS (cMP, 4.76 ± 2.32 days vs. rMP, 3.25 ± 1.10 days; p < 0.001), shorter operative time (cMP, 166.86 ± 51.62 min vs. rMP, 119.03 ± 33.71 min; p < 0.001), and lower intraoperative blood loss (cMP, 396.36 ± 392.04 ml vs. rMP, 225.75 ± 149.56 ml; p = 0.001) compared to the cMP group. There were no statistically significant differences in aneurysm obliteration rates or postoperative complication rates between the two approaches. The degree of TMA showed a favorable trend in the rMP cohort. The rMP offers significant advantages over the cMP in MCA UIA clipping, including shorter LOS, reduced operative time, lower intraoperative blood loss, and less severe TMA, without compromising aneurysm obliteration or increasing complication rates. These findings suggest that the rMP is a safe and effective alternative to the cMP for MCA aneurysm clipping.
- 26 April 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-11
Comparative study of the refined mini-pterional approach with reduced skin incision versus the conventional mini-pterional approach for clipping unruptured middle cerebral artery aneurysms: a propensity score-matched analysis
This study aimed to compare the safety and efficacy of the refined mini-pterional approach (rMP), utilizing a smaller skin incision, with the conventional mini-pterional approach (cMP) for microsurgical clipping of unruptured intracranial aneurysms (UIAs) in the middle cerebral artery (MCA). A retrospective cohort analysis was conducted, including 186 patients: 92 patients who underwent rMP between 2021 and 2022, and 94 patients treated with cMP between 2019 and 2020. Clinical outcomes included length of stay (LOS, days), operative time (minutes), intraoperative blood loss (ml), aneurysm obliteration rate, postoperative complication rates, and the severity of temporalis muscle atrophy (TMA). Propensity score matching (PSM) was employed to minimize selection bias and ensure comparability of baseline characteristics between the two cohorts. Following PSM, the rMP group demonstrated significantly reduced LOS (cMP, 4.76 ± 2.32 days vs. rMP, 3.25 ± 1.10 days; p < 0.001), shorter operative time (cMP, 166.86 ± 51.62 min vs. rMP, 119.03 ± 33.71 min; p < 0.001), and lower intraoperative blood loss (cMP, 396.36 ± 392.04 ml vs. rMP, 225.75 ± 149.56 ml; p = 0.001) compared to the cMP group. There were no statistically significant differences in aneurysm obliteration rates or postoperative complication rates between the two approaches. The degree of TMA showed a favorable trend in the rMP cohort. The rMP offers significant advantages over the cMP in MCA UIA clipping, including shorter LOS, reduced operative time, lower intraoperative blood loss, and less severe TMA, without compromising aneurysm obliteration or increasing complication rates. These findings suggest that the rMP is a safe and effective alternative to the cMP for MCA aneurysm clipping.
- Open Access
- 11 February 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 442
Preventative Effect of Angiotensin Receptor Blockers on Moderate-to-Severe Cerebral Vasospasm Among Patients Who Received Interventions for Aneurysmal Subarachnoid Hemorrhage
Objectives: We conducted a retrospective study to investigate the effectiveness of angiotensin receptor blockers (ARBs) in preventing moderate-to-severe cerebral vasospasm, which may influence patient outcomes in cases of subarachnoid hemorrhage resulting from aneurysmal rupture. Methods: Between 2016 and 2020, we treated 210 patients with aneurysmal subarachnoid hemorrhage (aSAH) caused by a ruptured cerebral aneurysm. We obtained the clinical and radiological characteristics of patients through medical records and divided them into two groups: those who were administered ARBs (ARB group) and those who were not (no-ARB group). Results: A total of 181 patients aged 19 years or older with aSAH, without vascular abnormalities (including vascular malformations and moyamoya disease), were enrolled in this study. The age of the enrolled patients was 59.01 ± 12.98 (mean ± standard deviation), and the sex ratio of males to females was 66:115, with a higher proportion of females. The ARB group had 29 and the no-ARB group had 152 participants. The overall incidence of moderate-to-severe vasospasm was 33.7%. The incidence of moderate-to-severe vasospasm in each group was 13.8% (4 patients) and 37.5% (57 patients), respectively. The Fisher grade (III–IV) [odds ratio (OR) of 2.732 (95% confidence interval [CI]: 1.343–5.560; p = 0.006)] independently increases the risk of moderate-to-severe vasospasm, while older age [OR = 0.963; 95% CI: 0.938–0.989; p = 0.006] and ARB administration [OR = 0.246; 95% CI: 0.079–0.771; p = 0.016] independently decrease this risk. Conclusions: Despite the potential adverse impacts associated with hypotension, the administration of ARBs may provide therapeutic benefits in preventing moderate-to-severe vasospasm. A multicenter randomized double-blind controlled trial is needed to further investigate the efficacy and safety of ARBs in preventing moderate-to-severe vasospasm in aSAH patients who have undergone interventions and are experiencing acute hypertension.
- 11 February 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 442
Open AccessPreventative Effect of Angiotensin Receptor Blockers on Moderate-to-Severe Cerebral Vasospasm Among Patients Who Received Interventions for Aneurysmal Subarachnoid Hemorrhage
Objectives: We conducted a retrospective study to investigate the effectiveness of angiotensin receptor blockers (ARBs) in preventing moderate-to-severe cerebral vasospasm, which may influence patient outcomes in cases of subarachnoid hemorrhage resulting from aneurysmal rupture. Methods: Between 2016 and 2020, we treated 210 patients with aneurysmal subarachnoid hemorrhage (aSAH) caused by a ruptured cerebral aneurysm. We obtained the clinical and radiological characteristics of patients through medical records and divided them into two groups: those who were administered ARBs (ARB group) and those who were not (no-ARB group). Results: A total of 181 patients aged 19 years or older with aSAH, without vascular abnormalities (including vascular malformations and moyamoya disease), were enrolled in this study. The age of the enrolled patients was 59.01 ± 12.98 (mean ± standard deviation), and the sex ratio of males to females was 66:115, with a higher proportion of females. The ARB group had 29 and the no-ARB group had 152 participants. The overall incidence of moderate-to-severe vasospasm was 33.7%. The incidence of moderate-to-severe vasospasm in each group was 13.8% (4 patients) and 37.5% (57 patients), respectively. The Fisher grade (III–IV) [odds ratio (OR) of 2.732 (95% confidence interval [CI]: 1.343–5.560; p = 0.006)] independently increases the risk of moderate-to-severe vasospasm, while older age [OR = 0.963; 95% CI: 0.938–0.989; p = 0.006] and ARB administration [OR = 0.246; 95% CI: 0.079–0.771; p = 0.016] independently decrease this risk. Conclusions: Despite the potential adverse impacts associated with hypotension, the administration of ARBs may provide therapeutic benefits in preventing moderate-to-severe vasospasm. A multicenter randomized double-blind controlled trial is needed to further investigate the efficacy and safety of ARBs in preventing moderate-to-severe vasospasm in aSAH patients who have undergone interventions and are experiencing acute hypertension.
- 1 October 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 141 (4) , 966-974
Prediction of postoperative cerebral infarction after combined bypass surgery in adult moyamoya disease: combining quantitative parameters on RAPID perfusion CT with clinically related factors
OBJECTIVE: The aim of this study was to identify predictive factors of postoperative cerebral infarction (PostCI) following combined bypass (CB) surgery in adult patients with moyamoya disease (MMD) using quantitative parameters from the rapid processing of perfusion and diffusion (RAPID) perfusion CT (PCT) software. METHODS: The authors retrospectively reviewed 276 total hemispheres in patients with MMD who underwent CB. Preoperative volumes of time-to-maximum (Tmax) > 4 sec and > 6 sec were obtained from the RAPID analysis of PCT. These quantitative parameters, along with other clinical and angiographic factors, were statistically analyzed to determine the significant predictors for PostCI following CB. RESULTS: PostCI occurred in 17 hemispheres (6.16%). PCA involvement (p = 0.016), and the volume of Tmax > 6 sec (p < 0.001) and Tmax > 4 sec (p < 0.001), were identified as variables related to PostCI in the univariable analysis. In the multivariable analysis, the volume of Tmax > 6 sec (OR 1.013, 95% confidence interval 1.007–1.019, p < 0.001) was determined to be an independent predictive factor significantly associated with PostCI after CB in adult patients with MMD. In the receiver operating characteristic (ROC) curve, the cutoff value of the preoperative volume of Tmax > 6 sec was determined to be 59.5 ml (sensitivity 82.4%, specificity 71.9%, area under the ROC curve 0.811). CONCLUSIONS: For adult patients with MMD and a large volume of Tmax > 6 sec over 59.5 ml, more caution is required when deciding to undergo bypass surgery and in postoperative management.
- 1 October 2024
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 141 (4) , 966-974
Prediction of postoperative cerebral infarction after combined bypass surgery in adult moyamoya disease: combining quantitative parameters on RAPID perfusion CT with clinically related factors
OBJECTIVE: The aim of this study was to identify predictive factors of postoperative cerebral infarction (PostCI) following combined bypass (CB) surgery in adult patients with moyamoya disease (MMD) using quantitative parameters from the rapid processing of perfusion and diffusion (RAPID) perfusion CT (PCT) software. METHODS: The authors retrospectively reviewed 276 total hemispheres in patients with MMD who underwent CB. Preoperative volumes of time-to-maximum (Tmax) > 4 sec and > 6 sec were obtained from the RAPID analysis of PCT. These quantitative parameters, along with other clinical and angiographic factors, were statistically analyzed to determine the significant predictors for PostCI following CB. RESULTS: PostCI occurred in 17 hemispheres (6.16%). PCA involvement (p = 0.016), and the volume of Tmax > 6 sec (p < 0.001) and Tmax > 4 sec (p < 0.001), were identified as variables related to PostCI in the univariable analysis. In the multivariable analysis, the volume of Tmax > 6 sec (OR 1.013, 95% confidence interval 1.007–1.019, p < 0.001) was determined to be an independent predictive factor significantly associated with PostCI after CB in adult patients with MMD. In the receiver operating characteristic (ROC) curve, the cutoff value of the preoperative volume of Tmax > 6 sec was determined to be 59.5 ml (sensitivity 82.4%, specificity 71.9%, area under the ROC curve 0.811). CONCLUSIONS: For adult patients with MMD and a large volume of Tmax > 6 sec over 59.5 ml, more caution is required when deciding to undergo bypass surgery and in postoperative management.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (23) , e188
Clinical Outcomes of Clipping and Coil Embolization for Ruptured Intracranial Aneurysms Categorized by Region and Hospital Size: A Nationwide Cohort Study in Korea
Won YD, et al. J Korean Med Sci. 2024 May;39:e188. https://doi.org/10.3346/jkms.2024.39.e188
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (23) , e188
Open AccessClinical Outcomes of Clipping and Coil Embolization for Ruptured Intracranial Aneurysms Categorized by Region and Hospital Size: A Nationwide Cohort Study in Korea
Won YD, et al. J Korean Med Sci. 2024 May;39:e188. https://doi.org/10.3346/jkms.2024.39.e188
- 23 December 2023
- Published by Elsevier in World Neurosurgery
- Vol. 189, e1-e14
Angiographic and Clinical Outcomes of Various Techniques of Intracranial-to-Intracranial Bypass for Complex Cases with a Review of Pertinent Literature and Illustrated Cases
- 23 December 2023
- Published by Elsevier in World Neurosurgery
- Vol. 189, e1-e14
Angiographic and Clinical Outcomes of Various Techniques of Intracranial-to-Intracranial Bypass for Complex Cases with a Review of Pertinent Literature and Illustrated Cases